NCT04994626 2021-08-06Ibrutinib Combined With Rituximab for Treatment of Relapsed Refractory MYD88 and CD79A/B (or CD79B Alone) DLBCL Who Have Received at Least Two Prior TherapiesChineseAMSPhase 2 Unknown20 enrolled
NCT03947736 2019-05-14Dynamic Monitoring of HER2 and ctDNA Specific Mutations in Patients With Recurrent or Metastatic Breast Cancer by Digital PCRChineseAMSUnknown200 enrolled
NCT01492556 2013-03-15Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast CancerChineseAMSPhase 2 Unknown100 enrolled